<DOC>
	<DOCNO>NCT00097578</DOCNO>
	<brief_summary>This observational study design follow patient metastatic locally advanced unresectable colorectal cancer receive Avastin combination chemotherapy whose cancer either previously untreated treat &lt; =4 month prior enrollment .</brief_summary>
	<brief_title>A Study Avastin With Chemotherapy Treatment Metastatic Advanced Unresectable Colorectal Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Signed Informed Consent Authorization document Metastatic , locally advance unresectable , adenocarcinoma colon rectum Receiving Avastin component firstline chemotherapy Firstline chemotherapy plus Avastin initiate &lt; =4 month prior enrollment study Patients contraindication treatment Avastin ( see Avastin Package Insert ) would incur excessive risk Avastin treatment ineligible study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>